MedPath

Anterior Temporal Epilepsy Neuropsychological Assessment of Faces

Not Applicable
Conditions
Anterior Temporal Lobectomy
Anterior Temporal Epilepsy
Face Perception
Registration Number
NCT02888925
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

The purpose is to evaluate neuropsychological effects of anterior temporal epilepsy in face perception by comparison of performances of epileptic patients and control individuals, sex-, age- and socio-educational level-matched.

Secondary purposes are to prospectively evaluate neuropsychological impact of anterior temporal lobectomy performed for surgical treatment of anterior temporal epilepsy on face perception (exploratory study).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria

ALL:

  • Informed consent
  • Affiliation to social security
  • Preliminary medical examination

PATIENTS WITH EPILEPSY:

  • Symptomatic drug-resistant anterior temporal epilepsy (confirmed with video-electroencephalography and magnetic resonance imaging and if necessary intracerebral SEEG exploration)
  • Patient needing anterior temporal lobectomy and undergoing pre-surgery conventional intercritical assessment for surgery decision
  • Nonverbal IQ ≥ 70 (WAIS-IV)
  • At least 6 successful VOSP tests (perception test)
Exclusion Criteria

ALL:

  • persons under legal protection or incapable to consent
  • Persons deprived of liberty by juridical or administrative decision

PATIENTS WITH EPILEPSY:

  • Sever visual disorders of neurological or ophthalmological origin

CONTROL INDIVIDUALS:

  • Psychiatric or neurological disorders
  • Important ophthalmological disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Scores obtained with Benton test by patients with anterior temporal epilepsy and matched control individualsday 0
Secondary Outcome Measures
NameTimeMethod
Change of scores obtained with Benton test by epilepsy patients before and after lobectomy and control individuals (only patients having undergone anterior temporal lobectomy and matched control individuals)day 0 and after 24 to 30 months

Trial Locations

Locations (1)

Service de Neurologie, Hôpital Central, CHU de Nancy

🇫🇷

Nancy, France

Service de Neurologie, Hôpital Central, CHU de Nancy
🇫🇷Nancy, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.